Egetis Therapeutics AB: European Commission approves Egetis' Emcitate (tiratricol) as the first and only treatment for patients with MCT8 deficiency
Egetis Therapeutics AB (publ) ("Egetis" or the "Company") (Nasdaq Stockholm: EGTX), today announced that the European Commission (EC) has approved Emcitate® (tiratricol) ...
Canada1d
HIV and AIDS: Symptoms and treatment
With treatment, people living with HIV can have long and healthy lives. However, if left untreated, it can cause a weakened immune system or acquired immune deficiency syndrome (AIDS). Some people may ...
Rocket Pharma Is A Buy At These Prices With Promising Data
Rocket Pharmaceuticals, Inc.'s innovative therapies show promise after FDA setbacks. With potential $1B+ markets, RCKT offers ...
Myriad Genetics, Inc.: Myriad Genetics Announces Two New Patents Granted for its Molecular Residual Disease (MRD) Assay
Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic and tumor genomic testing and precision medicine, announced that the United States Patent and ...
eLife10d
Drug combination prediction for cancer treatment using disease-specific drug response profiles and single-cell transcriptional signatures
retriever generates disease-specific transcriptional drug response signatures by merging transcriptional signatures over time, concentration, and cell-type. These signatures can then be matched to ...
ahajournals.org14d
Abstract WP401: Selenium deficient diet induces neuroinflammatory changes in aged mice which are compensated after chronic deficiency
We hypothesize that selenium deficiency increases oxidative stress and ROS-induced ... Brain and spleen were harvested after 3 months for flow cytometric (FC) analysis and immunohistochemistry (IHC).
Sky14d
'Groundbreaking' sickle cell treatment to be offered to NHS patients for first time
A "groundbreaking" £1.65 million treatment has been approved for use ... It is believed around 1,700 people could be eligible after the National Institute for Health and Care Excellence (Nice ...
Kenosha News14d
FDA approves new painkiller that shows promise and challenges of opioid alternatives
WASHINGTON — Federal officials approved a new type of pain drug Thursday designed to eliminate the risks of addiction and overdose associated with opioid medications like Vicodin and OxyContin ...
Sporting News15d
LiAngelo Ball record label, explained: How new song landed Ball brother $8M deal with Def Jam
After a few years out of the spotlight ... Ball inked a deal with Def Jam Records and its parent corporation, Universal Music Group, according to ESPN's Shams Charania. The deal is worth up ...
This is Money16d
Ultra-wealthy stunned after iconic old-money status symbol tanks in value
Manhattan's richest residents have been left stunned after their old money co-op buildings ... York's Central Park were once an imposing status symbol and a reliable financial asset - but not ...
BioSpace17d
Saol Therapeutics announces FDA acceptance of New Drug Application for SL1009 for treatment of Pyruvate Dehydrogenase Complex Deficiency
DCA will be used with a proprietary genetic test to treat an orphan pediatric mitochondrial disease, Pyruvate Dehydrogenase Complex Deficiency (PDCD ... improvement in safety or effectiveness of the ...